Getting Doctors and Technologists to Talk About Artificial Intelligence

On the occasion of the Artificial Intelligence Appreciation Day, a conference will be held at the Champalimaud Foundation aimed at bridging the gap between AI innovation and its implementation in medical practice.

The goal of the MEDICA AI - The Conference, which will take place on July 16 at the Champalimaud Foundation (FC), is to familiarise healthcare professionals, with the latest AI tools so that they can apply them in their daily practice for the benefit of patients.

Join us for the FAITH Project's closing conference, where we'll delve into the crucial intersection of the FAITH AI technology and trials as well as key issues of mental health, survivorship in cancer and lessons learnt.

Meeting Description

This meeting collaboration between the Association for Cancer Immunotherapy CIMT and the Champalimaud Foundation will address promising paths towards effective cellular treatment modalities for patients with solid cancer and discuss the boundaries of synthetically engineered immune cells. The meeting will also discuss the innovation gap between academic and small biotech driven research, and the challenges of safe, biologically, and clinically relevant phase I / II clinical trials. 

Description

Nuno Prego Ramos, co-founder and CEO of CellmAbs, will share the journey of CellmAbs, from it's early days starting with an initial technology from NOVA University to becoming a pioneering force in cancer therapy innovation.

In this talk, we will hear about the strategic decisions, challenges and breakthroughs that propelled the company to its selling the assets to the pharmaceutical giant, BioNTech.

Part I of the series of Ar Events under the motto “Roots of AI” was about the past – the history of artificial intelligence". Now, the “Creative Directors” and the invited speakers of Part II of the series, which took place at the Champalimaud Foundation (CF) last month, undertook to discuss the now of AI, sharing their views on the pros and cons of the technology. Part III (the last event of the series) will take place on May 7th and will deal with the future of AI.

Host

Carlos Minutti, Principal Investigator, Champalimaud Research

Venue

Seminar room

Do you know all about Non-Melanoma Skin Cancer (NMSC)?

We are thrilled to announce that the registrations for the NMSC Symposium “Non-Melanoma Skin Cancer. What do we know?”, hosted by the Champalimaud Foundation on the 7th of June, are now open!

This event will be a fusion of clinical expertise and research advancements, bringing together experts and healthcare professionals to discuss the latest research findings and clinical developments in the diagnosis and treatment of Non-Melanoma Skin Cancer.

This year's 7th Champalimaud Cancer Nurse Conference is poised to explore the theme inspired by Bob Dylan's iconic song "The Times They Are A-Changin'".

In an constantly evolving world, the ability to adjust to emerging realities is a necessity. Within the healthcare sector, this principle significantly influences the restructuring of services and patient care.

Location & Dates: Champalimaud Foundation, April 15th -19th 

Application deadline: March 1st

Acceptance notification: March 15th

Cost: €150 (payment deadline March 22nd)

Capacity: 20 Students

The course is scheduled to take place at the Champalimaud Institute in Lisbon from April 15 to April 19, 2024, and will be limited to 20 students.

The symposium will be organised as a single-track scientific meeting and count with keynote & invited speakers, talks selected from abstracts and a poster session together with other networking and social activities. It will be held on the 11^th and 12^th of March, 2024 at the Main Auditorium of the Champalimaud Foundation in Lisbon, Portugal.